FINISHED DOSAGE FORMS

Extrovis Icon

The key pillars of our balanced FDF portfolio strategy are:

  • Niche/ under the radar opportunities – Segments that are less visible without in-depth market research
  • Innovation driven portfolio focusing on formulation improvements offering increased bioavailability, patient compliance and convenience, overall cost efficiency of therapy and/or medical waste management
Extrovis Icon
0
+
ACTIVE COMPLEX PROJECTS
0
+
SCIENTISTS
0
+
PATENTS
0
+
NDAs OF INNOVATION PORTFOLIO
Extrovis Content Image

Backward Integration of Key Projects

In-house development of critical or low availability APIs to ensure long term cost competitiveness and supply chain continuity.

FDF Research & Development

Extrovis’ R&D team applies a cross-functional approach utilizing expertise from multiple disciplines such as analytical, engineering, quality assurance, clinical and regulatory affairs.
Our state-of-the-art development center with a team over 30 scientists has proven track record of taking highly complex products and unique technologies from a portfolio concept all the way to commercialization.

Regulatory Affairs

Extrovis’ regulatory team is capable of developing regulatory strategies, manage dossier submissions and compliance across the globe. Our area of activity now also includes, besides the US and EU, China, Brazil, and other global markets.